IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0443270
(2006-05-31)
|
등록번호 |
US-8399209
(2013-03-19)
|
발명자
/ 주소 |
- Schelp, Carsten
- Trier, Michael
- Kirakossian, Hrair
|
출원인 / 주소 |
- Siemens Healthcare Diagnostics Products GmbH
|
대리인 / 주소 |
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
|
인용정보 |
피인용 횟수 :
0 인용 특허 :
27 |
초록
▼
The invention relates to methods for the quantitative or qualitative detection of an analyte in an assay and adequate reagents therefor, particularly a homogeneous binding test. According to the invention, an analyte-specific binding partner R1 comprises more than one specific binding point for a sp
The invention relates to methods for the quantitative or qualitative detection of an analyte in an assay and adequate reagents therefor, particularly a homogeneous binding test. According to the invention, an analyte-specific binding partner R1 comprises more than one specific binding point for a specific binding partner X that is associated with a component of a signal-forming system while a second analyte-specific binding partner R2 comprises more than one specific binding point for a specific binding partner Y which is also associated with a component of a signal-forming system.
대표청구항
▼
1. A homogeneous method for quantitatively or qualitatively detecting an analyte in a sample (sample analyte) comprising (1) contacting the sample with (a) a first conjugate molecule comprising an analyte-specific binding partner R1 and possessing specific binding sites for a specific binding partne
1. A homogeneous method for quantitatively or qualitatively detecting an analyte in a sample (sample analyte) comprising (1) contacting the sample with (a) a first conjugate molecule comprising an analyte-specific binding partner R1 and possessing specific binding sites for a specific binding partner X, wherein R1 is capable of binding to the analyte or to an analyte-specific binding partner R2;(b) a second conjugate molecule comprising an analyte-specific binding partner R2 and possessing specific binding sites for a specific binding partner Y, wherein R2 is capable of binding to the analyte or to R1;(c) the specific binding partner X, which is associated with a first component of a signal-generating system; and(d) the specific binding partner Y, which is associated with a second component of the signal-generating system;wherein at least one of the conjugates comprising R1 or R2 possesses more than one binding site for the respective specific binding partner X or Y;wherein the first and second components of the signal-generating system enter into a detectable interaction when spatially close to each other and the detectable interaction comprises a direct energy transfer between the components;wherein (i) both R1 and R2 are able to bind specifically to the sample analyte, or (ii) only R1 is able to bind specifically to the sample analyte and R2 can compete with the sample analyte in binding to R1; and(2) detecting the analyte in the sample (sample analyte) by measuring the magnitude of the interaction between the components of the signal-generating system;wherein said method is a homogeneous binding test. 2. The method of claim 1, wherein R1 is bound to the component of the signal-generating system by way of X during or after the binding reaction with the analyte. 3. The method of claim 1, wherein the number of binding sites possessed by the conjugate comprising R1 for the specific binding partner X is at least 2. 4. The method of claim 1, wherein the number of binding sites possessed by the conjugate comprising R2 for the specific binding partner Y is at least 2. 5. The method of claim 1, wherein R1 and R2 are the same analyte-specific binding partner. 6. The method of claim 1, wherein R1 and R2 are able to bind specifically to the sample analyte. 7. The method of claim 1, wherein the binding sites possessed by the conjugate comprising R1 for the specific binding partner X are chosen from hapten, antigen, biotin, digoxigenin, fluorescein, single-stranded nucleic acid chain, and dinitrophenol. 8. The method of claim 1, wherein the binding sites possessed by the conjugate comprising R2 for the specific binding partner Y are chosen from hapten, antigen, biotin, digoxigenin, fluorescein, single-stranded nucleic acid chain, and dinitrophenol. 9. The method of claim 1, wherein X and Y are the same specific binding partner. 10. The method of claim 1, wherein X is avidin, streptavidin, an anti-digoxigenin antibody, an anti-dinitrophenol antibody, a single-stranded nucleic acid chain, an anti-hapten antibody, an enzyme, or an enzyme substrate, or an antibody which specifically binds to a peptide antigen. 11. The method of claim 1, wherein Y is avidin, streptavidin, an anti-digoxigenin antibody, an anti-dinitrophenol antibody, a single-stranded nucleic acid chain, an anti-hapten antibody, an enzyme, or an enzyme substrate, or an antibody which specifically binds to a peptide antigen. 12. The method of claim 1, wherein the components of the signal-generating system are brought to a distance from each other which permits a detectable interaction between these components, as a result of the analyte being bound to at least one of R1 and R2. 13. The method of claim 1, wherein the components of the signal-generating system are not brought to a distance from each other which permits a detectable interaction between these components, as a result of R1 being bound by sample analyte in competition with R2. 14. The method of claim 1, wherein the components of the signal-generating system are microparticles associated with photosensitizers or microparticles associated with chemiluminescent substances. 15. The method of claim 1, wherein R2 is bound to components of the signal-generating system by way of Y during or after the binding reaction with the analyte. 16. The method of claim 3, wherein the number of binding sites possessed by the conjugate comprising R1 for the specific binding partner X is at least 5. 17. The method of claim 3, wherein the number of binding sites possessed by the conjugate comprising R1 for the specific binding partner X is at least 10. 18. The method of claim 3, wherein the number of binding sites possessed by the conjugate comprising R1 for the specific binding partner X is at least 15. 19. The method of claim 4, wherein the number of binding sites possessed by the conjugate comprising R2 for the specific binding partner Y is at least 5. 20. The method of claim 4, wherein the number of binding sites possessed by the conjugate comprising R2 for the specific binding partner Y is at least 10. 21. The method of claim 4, wherein the number of binding sites possessed by the conjugate comprising R2 for the specific binding partner Y is at least 15. 22. The method of claim 14, wherein the microparticles are latex particles. 23. The method of claim 1, wherein the first component of the signal-generating system is an energy donor and the second component of the signal-generating system is an energy recipient. 24. The method of claim 1, wherein one component of the signal-generating system is a photosensitizer. 25. The method of claim 1, wherein at least one component of the signal-generating system is a fluorophore. 26. The method of claim 1, wherein at least one of the analyte-specific binding partners R1 and R2 is an antibody. 27. The method of claim 1, wherein both analyte-specific binding partners R1 and R2 are antibodies. 28. The method of claim 1, wherein the first and second conjugates further comprise a carrier molecule to which are bound the analyte-specific binding partners R1 and R2 and the specific binding sites for the specific binding partners X and Y. 29. The method of claim 1, wherein the specific binding partners X and Y are bound to microparticles that also comprise the components of the signal-generating system.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.